New York - Emidio Zorzella, Chairman and CEO of Antares Vision Group, will be presenting the work of Antares Vision Group , and investments the Company has made in fighting counterfeit and dangerous drugs in Africa. Emidio is attending the 78th Session of the UN General Assembly and speaking on health and technology at the Sub-Saharan Africa Business Investment Summit.

"Every year, counterfeit and dangerous drugs lead to hundreds of thousands of deaths in Africa. Earlier this year, 60 children in The Gambia alone were poisoned by contaminated cough syrup. These needless losses are hurting families across the African continent, but this crisis is preventable and has reached a point where it can no longer be ignored," states Emidio Zorzella. "Antares Vision Group, with its rfxcel pharmaceutical track & trace technology, is proud to be working with the President of Guinea-Bissau, The Honorable Umaro Sissoco Embaló, as he takes the lead in Africa to stop counterfeit drugs with our traceability systems. We are proud to invest in Africa to deliver solutions to save the lives of so many people and we look forward to doing so across the continent."

His Excellency Ambassador Serge Mombouli of the Republic of Congo, who also serves as the Dean of the African Diplomatic Corps in Washington, DC, offered his support for the goal of eliminating counterfeit drugs in Africa. “This is a priority for President Denis Sassou Nguesso of the Republic of the Congo and it is my pleasure to invite you to my country to meet him and his health officials to discuss adoption of the rfxcel system to provide drug safety and security for our people” says Serge Mombouli.

Governments around the world are beginning to take control of their supply chains, as they realize how dependent we all are. Criminals, opportunists, and even terrorist groups, have begun capitalizing on the weaknesses of the global supply chain, and Antares Vision Group, through its Government Services team, is helping elected officials and Government organizations to strengthen protections for the health and safety of the public. Governments and Antares Vision Group have found success by partnering with various stakeholders in the supply chain to increase patient safety, eliminate the funding sources of criminal organizations, and provide a return on investment to all stakeholders.